Plain-English translation of NCT03299569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is building a complete picture of takotsubo cardiomyopathy—a rare condition where the heart's main pumping chamber weakens suddenly, often triggered by extreme stress or illness. Researchers are gathering medical data from all Scottish patients diagnosed with this condition since 2010 and comparing them to people who have had heart attacks and people without heart disease, to understand how common it is, who gets it, and what happens over time.
Very little is known about how often takotsubo cardiomyopathy occurs or how it affects patients long-term compared to other heart conditions. This study aims to fill that gap by creating a complete registry and understanding the real-world patterns of this serious but often overlooked condition.
You likely qualify if…
You likely don't qualify if…
If you have takotsubo cardiomyopathy, researchers will gather your existing medical records and health information from Scottish health records systems—you won't need to attend visits or undergo new tests. Your data will be linked with information from the healthcare system to track your health outcomes, medications, and recovery over time. This is a registry study, so participation is primarily about allowing researchers to use your medical information that already exists.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom
NHS Tayside, NHS Lothian
Enrollment target
~800 participants
Started
July 2016
Primary completion
December 2028
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dana Dawson, MD, MRCP
University of Aberdeen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.